F L O R I D A' S C O L L E G E S O F P H A R M A C Y
The Florida A&M College of Pharmacy and Pharmaceutical Sciences Institute of Public Health MOVING IN THE RIGHT DIRECTION In recent years, new NAPLEX requirements changed the face of testing results for many colleges and schools of pharmacy nationally. Like others, the our program is bouncing back. The graph below depicts an upswing towards positive outcomes. “The college is dedicated to providing learners with resources to assist in NAPLEX preparation. RxPrep coursebooks, online access and a three-day live review are the main resources given to learners during their fourth professional year. Additionally, learners must pass a comprehensive examination with 75 percent. Holding learners accountable for passing the examination helped increase our scores by 8 points last year,” said Dr. Jocelyn Spates, associate dean and professor of clinical affairs. Dr. Gallop Franklin, assistant professor of pharmacy practice added, “We are continuously reviewing courses within the curriculum. We are analyzing performance data on comprehensive exams such as the PCOA, NAPLEX and exit exams to make data-driven decisions that help develop our learners’ academic strengths.” Dr. Mandip Sachdeva Receives Consortium for Medical Marijuana Clinical Outcomes Research Grant Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health Pharmaceutical Sciences Professor Mandip Sachdeva, Ph.D., was awarded funding for his grant proposal entitled “Hyaluronic acid-functionalized, Cannabidiol-loaded Mesenchymal Stem Cells (MSC)-Derived Exosomes for Drug-Resistant Cancers” through the Consortium for Medical Marijuana Clinical Outcomes Research Grants Program. Dr. Mandip Sachdeva The Consortium for Medical Marijuana Clinical Outcomes 12
|
FLORIDA PHARMACY TODAY
Research, composed of public and private universities, is engaged in research on clinical outcomes of medical marijuana. The consortium will evaluate the safety and effectiveness of medical marijuana and consider dosing and routes of administration, including the study of the effects of smoking medical marijuana versus other methods of consumption. Funding recommendations were made after thoughtful and careful consideration at the MMJ Clinical Outcomes Consortium Research Board meeting in fall 2019. Out of 41 proposal submissions by investigators from different consortium member institutions for the 2019 funding cycle, Dr. Sachdeva’s proposal was one of the 10 chosen. His proposal for $71,250 was approved for the period of Dec. 1 through July 31. “We would like to applaud Dr. Sachdeva for his excellent grantsmanship and significant accomplishment in securing extramural funding,” said Associate Dean of Pharmaceutical Sciences Selina Darling-Reed, Ph.D. “His continued excellence is an inspiration to us all.” FAMU COPPS, IPH CPE Program Reaccredited, Continues to Deliver Exceptional CPE Programs The Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health’s Office of Continuing Pharmacy Education has been reaccredited by
